| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
in00005771321 |
| 005 |
20260327173932.5 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
230116t20242024pauab ob 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d N$T
|d USU
|d OPELS
|d INM
|d UKMGB
|d VRC
|d OCLCF
|d CASUM
|d OCLCO
|d OCLCL
|d OCLCQ
|d UKAHL
|d OCLCL
|
| 015 |
|
|
|a GBC3A3969
|2 bnb
|
| 016 |
7 |
|
|a 021000238
|2 Uk
|
| 020 |
|
|
|a 9780323790598
|q (electronic bk.)
|
| 020 |
|
|
|a 0323790593
|q (electronic bk.)
|
| 020 |
|
|
|z 0323790585
|q (hardcover)
|
| 020 |
|
|
|z 9780323790581
|q (hardcover)
|
| 035 |
|
|
|a (OCoLC)1356982399
|
| 037 |
|
|
|a 9780323790598
|b Ingram Content Group
|
| 050 |
|
4 |
|a QR189
|b .V268 2024eb
|
| 060 |
|
4 |
|a QW 805
|b P729 2018
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 069000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 028000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.372
|2 23
|
| 049 |
|
|
|a TXAM
|
| 130 |
0 |
|
|a Vaccines (Plotkin)
|
| 245 |
1 |
0 |
|a Plotkin's vaccines /
|c [edited by] Walter A. Orenstein, Paul A. Offit, Kathryn M. Edwards, Stanley A. Plotkin.
|
| 246 |
3 |
0 |
|a Vaccines
|
| 250 |
|
|
|a 8th edition.
|
| 264 |
|
1 |
|a Philadelphia, PA :
|b Elsevier,
|c [2024]
|
| 264 |
|
4 |
|c ©2024
|
| 300 |
|
|
|a 1 online resource :
|b illustrations (some color), color maps
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Previous edition: 2018.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Section 1. General aspects of vaccination. A short history of vaccination ; Vaccine immunology ; Correlates of protection ; The vaccine industry ; Vaccine manufacturing ; Evolution of adjuvants across the centuries ; Vaccine additives and manufacturing residuals in vaccines licensed in the united states ; Passive immunization ; General immunization practices -- Section 2. Licensed vaccines and vaccines in development. Adenovirus vaccines ; Anthrax vaccines ; Biodefense and special pathogen vaccines ; Cancer vaccines ; Cholera vaccines ; Combination vaccines ; Cytomegalovirus vaccines ; Dengue vaccines ; Diarrhea caused by bacteria ; Diphtheria toxoid ; Ebola vaccines ; Enterovirus 71 ; Epstein-Barr virus vaccines ; Haemophilus influenzae type b vaccines ; Hepatitis A vaccines ; Hepatitis B vaccines ; Hepatitis C vaccines ; Hepatitis E vaccines ; Herpes simplex virus vaccines ; Human immunodeficiency virus vaccines ; Human papillomavirus vaccines ; Inactivated influenza vaccines ; Influenza vaccine ; live ; Japanese encephalitis vaccines ; Lyme disease vaccines ; Malaria vaccines ; Maternal immunization ; Measles vaccines ; Meningococcal capsular group A, C, W, and Y conjugate vaccines ; Meningococcal capsular group B vaccines ; Mumps vaccines ; Noninfectious disease vaccines ; Norovirus vaccines ; Parasitic disease vaccines ; Pertussis vaccines ; Plague vaccines ; Pneumococcal conjugate vaccine and pneumococcal common protein vaccines ; Pneumococcal polysaccharide vaccines ; Poliovirus vaccine-inactivated ; Poliovirus vaccine-live ; Rabies vaccines ; Respiratory syncytial virus vaccines ; Rotavirus vaccines ; Rubella vaccines ; Smallpox and vaccinia ; Staphylococcus aureus vaccines ; Streptococcus group a vaccines ; Streptococcus group B vaccines ; Tetanus toxoid ; Tickborne encephalitis vaccines ; Tuberculosis vaccines ; Typhoid fever vaccines ; Varicella vaccines ; Yellow fever vaccines ; Zika virus ; Zoster vaccines -- Section 3. New technologies. Technologies for making new vaccines ; Development of gene-based vectors for immunization ; Technologies to improve immunization -- Section 4. Vaccination of special groups. Vaccination of immunocompromised hosts ; Vaccination of human immunodeficiency virus-infected persons ; Vaccines for international travel ; Vaccines for healthcare personnel -- Section 5. Public health and regulatory issues. Immunization in the United States ; Immunization in Europe ; Immunization in the Asia-Pacific region ; Immunization in developing countries ; Community protection ; Economic analyses of vaccine policies ; Regulation and testing of vaccines ; Regulation of vaccines in Europe ; Regulation of vaccines in low- and middle-income countries ; Vaccine safety ; Legal issues ; Ethics.
|
| 520 |
|
|
|a "From the latest vaccination evidence, recommendations, and protocols . . . to new vaccine development and the use of vaccines in reducing disease, Plotkin's Vaccines, 8th Edition, covers every aspect of vaccination. Now completely revised and updated from cover to cover, this award-winning text continues to provide reliable information from global authorities, offering a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin's Vaccines is a must-have reference for current, authoritative information in this fast-moving field." --
|c Provided by publisher.
|
| 588 |
0 |
|
|a Online resource; title from table of contents page (Elsevier ClinicalKey, viewed May 31, 2023).
|
| 650 |
|
0 |
|a Vaccines.
|
| 650 |
|
0 |
|a Vaccination.
|
| 650 |
1 |
2 |
|a Vaccines
|
| 650 |
2 |
2 |
|a Vaccination
|
| 650 |
2 |
2 |
|a Immunization Programs
|
| 650 |
|
6 |
|a Vaccins.
|
| 650 |
|
6 |
|a Vaccination.
|
| 650 |
|
7 |
|a Vaccines
|2 fast
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 655 |
|
4 |
|a Maps.
|
| 700 |
1 |
|
|a Orenstein, Walter A.,
|e editor
|1 https://isni.org/isni/000000011604396X
|
| 700 |
1 |
|
|a Offit, Paul A.,
|e editor.
|1 https://isni.org/isni/000000007693402X
|
| 700 |
1 |
|
|a Edwards, Kathryn M.,
|e editor.
|
| 700 |
1 |
|
|a Plotkin, Stanley A.,
|d 1932-
|e editor.
|1 https://id.oclc.org/worldcat/entity/E39PBJwMHcjgVk8PBhxVvTjjYP
|1 https://isni.org/isni/0000000108875133
|
| 710 |
2 |
|
|a ScienceDirect (Online service)
|
| 758 |
|
|
|i has work:
|a Vaccines (Plotkin) (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGf43DjjDgBHcm9dr3tfHK
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|t PLOTKIN'S VACCINES.
|d [S.l.] : ELSEVIER - HEALTH SCIENCE, 2023
|z 0323790585
|w (OCoLC)1330195987
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://www.sciencedirect.com/science/book/9780323790581
|z Connect to the full text of this electronic book
|t 0
|
| 936 |
|
|
|a BATCHLOAD
|
| 955 |
|
|
|a Elsevier ScienceDirect 2026-2027
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
f |
f |
|i 0ef3c9b7-fdc7-4508-bab4-af47a3e3d99f
|s bbc6f482-3c7c-40fc-be31-9cafd88279a4
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s www_evans
|d Available Online
|t 0
|e QR189 .V268 2024eb
|h Library of Congress classification
|
| 998 |
f |
f |
|a QR189 .V268 2024eb
|t 0
|l Available Online
|